Greg Maurer is the Managing Director and founder of Heron Capital. See sector focus and contact routes.
Greg Maurer is the Managing Director and founder of Heron Capital, a private investment firm established in 2005 that he previously led as Managing Partner before serving as a corporate attorney at Schiff Hardin in Chicago focusing on mergers and acquisitions and venture finance. Heron Capital targets small to middle-market companies in niche manufacturing and healthcare sectors, primarily across North America, with an investment thesis centered on acquiring firms with defensible market positions for long-term operational improvement. The firm typically executes investments ranging up to $20 million, such as its Series C lead in NeoChord, and often acts as a lead investor in recapitalizations or acquisitions rather than following later-stage rounds. Notable portfolio companies include Arcamed, a surgical case-tray manufacturer; NeoChord, a minimally invasive heart valve repair company; AirXpanders, and BioSet. Maurer has held executive roles at portfolio firms like Arcamed as Executive Chairman and previously served as a director at Aptus Endosystems and NeoChord, reflecting a hands-on operational approach. While he has not published distinctive pu
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Carmel.
Investors like Greg Maurer · Full investor directory · Investor access · Company funding database